EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C22H21N7O2 |
| Net Charge | 0 |
| Average Mass | 415.457 |
| Monoisotopic Mass | 415.17567 |
| SMILES | Cn1c(=O)n([C@H]2CCCN(C(=O)CC#N)C2)c2nc(-c3cnn4ccccc34)ccc21 |
| InChI | InChI=1S/C22H21N7O2/c1-26-19-8-7-17(16-13-24-28-12-3-2-6-18(16)28)25-21(19)29(22(26)31)15-5-4-11-27(14-15)20(30)9-10-23/h2-3,6-8,12-13,15H,4-5,9,11,14H2,1H3/t15-/m0/s1 |
| InChIKey | ASOKEXGIQLZRHH-HNNXBMFYSA-N |
| Roles Classification |
|---|
| Applications: | anti-asthmatic agent Any compound that has anti-asthmatic effects. anti-inflammatory agent Any compound that has anti-inflammatory effects. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| frevecitinib (CHEBI:759931) has role anti-asthmatic agent (CHEBI:65023) |
| frevecitinib (CHEBI:759931) has role anti-inflammatory agent (CHEBI:67079) |
| frevecitinib (CHEBI:759931) is a pyrazolopyridine (CHEBI:46699) |
| INN | Source |
|---|---|
| frevecitinib | WHO MedNet |
| Synonym | Source |
|---|---|
| KN-002 | ChEMBL |